Skip to content
OpenCapital
Get started

Align Technology ALGN Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

3M logo
3MMMM
$302M-66.6%
Globus Medical logo
Globus MedicalGMED
$25.96M+131%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$12.3M-26.3%

Other financials

Income statement

See full
Revenue$1.0B+6.2%
Gross profit$736.6M+8.3%
Operating income$142.0M+8.3%
Net income$112.8M+21.0%
EPS (diluted)$1.57+23.6%

Balance sheet

See full
Cash & equivalents$1.1B+21.4%
Total debt$116.0M-2.1%
Total equity$4.1B+9.4%
Total assets$6.3B+3.5%

Cash flow

See full
Operating cash flow$151.0M+187%
CapEx$30.8M+21.7%
Free cash flow$120.3M+339%

Valuation

See full
Market cap$13.04B+4.5%
Enterprise value$12.1B+3.1%
P/E30.3×-0.1×
P/S3.2×0.0×

Profitability

See full
Gross margin67.6%-2.3pp
Operating margin13.6%-1.1pp
Net margin10.5%+0.2pp
FCF margin14.3%-1.6pp

Returns & leverage

See full
Return on equity10.8%0.0pp
Debt / equity0×0.0×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by Align Technology in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Align Technology’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Align Technology's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Align Technology's stock issuance proceeds?
Align Technology (ALGN) reported stock issuance proceeds of $11.72M in Q1 2026.
How has Align Technology's stock issuance proceeds changed year-over-year?
Align Technology's stock issuance proceeds decreased by 15.8% year-over-year, from $13.91M to $11.72M.
What does stock issuance proceeds mean?
Cash inflow from selling company shares to employees or the public.
How do you interpret stock issuance proceeds?
Higher values often correlate with increased employee participation in stock plans or capital raises to bolster liquidity.
How does stock issuance proceeds compare across companies?
Standard across public companies with active equity compensation programs; generally predictable based on vesting schedules.